CJC-1295 / Ipamorelin — Peptide Blend Research Compound

Catalog ID: IPAC | CAS: CJC-1295 (863288-34-0) / Ipamorelin (170851-70-4)

Blend Overview

CJC-1295 / Ipamorelin is a synergistic peptide research blend consisting of a GHRH analog (CJC-1295) and a GHS receptor agonist (Ipamorelin).
The blend is provided for preclinical studies exploring growth hormone secretagogue synergy, receptor activation kinetics, and somatotropic signaling pathways.
Not for human consumption or therapeutic use.

Peptide Components

• CJC-1295 (GHRH analog) — Stimulates the GHRH receptor, enhancing natural GH release in a pulsatile pattern.
• Ipamorelin (GHS analog) — A selective growth hormone secretagogue receptor (GHSR) agonist that augments GH signaling via ghrelin receptor activation.

Molecular Characteristics

• CJC-1295 — Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Gln-Ser-Ser-Gly-Ala-Pro-Gly-Lys-Lys-NH₂
• Ipamorelin — Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂
• Molecular Weight (CJC-1295): ≈ 3647.1 g/mol
• Molecular Weight (Ipamorelin): ≈ 711.9 g/mol
• Purity: ≥ 98 % (HPLC)
• Formulation: Lyophilized peptide blend (sterile vial)

Physical Properties

• Appearance: White to off-white powder
• Solubility: Sterile water or 0.6 % acetic acid (research use only)
• Container: Sterile sealed vial

Storage & Stability

• Unreconstituted: Store at −20 °C, protected from light and moisture.
• Reconstituted: Aliquot and store at −20 °C; avoid repeated freeze–thaw cycles.

Research Context

This blend is used in in vitro and in vivo models to explore somatotropic signaling synergy and pituitary receptor co-activation.
Researchers employ the CJC-1295 / Ipamorelin combination to study growth hormone secretion patterns, endocrine modulation, and peptide feedback loops within controlled laboratory environments.